Insulin receptor, insulin receptor substrate-1, Raf-1, and Mek-1 during hormonal hepatocarcinogenesis by intrahepatic pancreatic islet transplantation in diabetic rats

Cancer Research

Volumn 64, Issue 21, 2004, Pages 8093-8100

  Evert, Matthias ^a,b   Sun, Jianping ^b,c   Pichler, Sabine ^b   Slavova, Nadia ^b,d   Schneider Stock, Regine ^a   Dombrowski, Frank ^a,b  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b UNIVERSITY OF BONN   (Germany)

^c CHILDREN S HOSPITAL LOS ANGELES   (United States)

^d HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; LIVER PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; PANCREAS HORMONE; RAF PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASOPHIL; CELL MEMBRANE; CLEAR CELL CARCINOMA; CONTROLLED STUDY; CYTOPLASM; DIABETES MELLITUS; ELECTRON MICROSCOPY; GENE EXPRESSION; GENE OVEREXPRESSION; GENE TRANSLOCATION; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LIVER; LIVER ADENOMA; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MALE; NONHUMAN; PANCREAS ISLET CELL; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; ISLETS OF LANGERHANS TRANSPLANTATION; LIVER NEOPLASMS, EXPERIMENTAL; MALE; MAP KINASE KINASE 1; PHOSPHOPROTEINS; PRECANCEROUS CONDITIONS; PROTO-ONCOGENE PROTEINS C-RAF; RATS; RATS, INBRED LEW; RECEPTOR, INSULIN; RNA, MESSENGER; SIGNAL TRANSDUCTION; STREPTOZOCIN;

EID: 7444249697     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-2040     Document Type: Article

References (49)

1. Bucher ML, Swaffield, MN. Regulation of hepatic regeneration in rats by synergistic action of insulin and glucagon. Proc Natl Acad Sci USA 1975;72:1157-60.
2. Francavilla A, Starzl TE, Porter K, et al. Screening for candidate hepatic growth factors by selective portal infusion after canine Eck's fistula. Hepatology 1991;14:665-70.
3. Kahn CR, Goldfine AB. Molecular determinants of insulin action. J Diabetes Complications 1993;7:92-105.
4. O'Brien RM, Granner DK. Regulation of gene expression by insulin. Physiol Rev 1996;76:1109-61.
5. O'Brien RM, Streeper RS, Ayala JE, Stadelmaier BT, Hornbuckle LA. Insulin-regulated gene expression. Biochem Soc Trans 2001;29:552-8.
6. Starzl TE, Watanabe K, Porter KA, Putnam CW. Effects of insulin, glucagon, and insulin/glucagon infusions on liver morphology and cell division after complete portacaval shunt in dogs. Lancet 1976;1:821-5.
7. Cheatham B, Kahn CR. Insulin action and the insulin signaling network. Endocr Rev 1995;16:117-42.
8. Smith RM, Harada S, Jarett L. Insulin internalization and other signaling pathways in the pleiotropic effects of insulin. Int Rev Cytol 1997;173:243-80.
9. White MF, Maron R, Kahn CR. Insulin rapidly stimulates tyrosine phosphorylation of a Mr-185,000 protein in intact cells. Nature (Lond) 1985;318:183-6.
10. White MF, Kahn CR. The insulin signaling system. J Biol Chem 1994;269:1-4.
11. Manchester J, Kong X, Lowry OH, Lawrence JC Jr. Ras signaling in the activation of glucose transport by insulin. Proc Natl Acad Sci USA 1994;91:4644-8.
12. Bergmann U, Funatomi H, Kornmann M, Beger HG, Korc M. Increased expression of insulin receptor substrate-1 in human pancreatic cancer. Biochem Biophys Res Commun 1996;220:886-90.
13. Chang Q, Li Y, White MF, Fletcher JA, Xiao S. Constitutive activation of insulin receptor substrate 1 is a frequent event in human tumors: therapeutic implications. Cancer Res 2002;62:6035-8.
14. Frittitta L, Cerrato A, Sacco MG, Weidner N, Goldfine ID, Vigneri R. The insulin receptor content is increased in breast cancers initiated by three different oncogenes in transgenic mice. Breast Cancer Res Treat 1997;45:141-7.
15. Furusaka A, Nishiyama M, Ohkawa K, et al. Expression of insulin receptor substrate-1 in hepatocytes: an investigation using monoclonal antibodies. Cancer Lett 1994;84:85-92.
16. Ito T, Sasaki Y, Wands JR. Overexpression of human insulin receptor substrate 1 induces cellular transformation with activation of mitogen-activated protein kinases. Mol Cell Biol 1996;16:943-51.
17. Nehrbass D, Klimek F, Bannasch P. Overexpression of insulin receptor substrate-1 emerges early in hepatocarcinogenesis and elicits preneoplastic hepatic glycogenosis. Am J Pathol 1998;152:341-5.
18. Nehrbass D, Klimek F, Bannasch P, Mayer D. Insulin receptor substrate-1 is overexpressed in glycogenotic but not in amphophilic preneoplastic hepatic foci induced in rats by N-nitrosomorpholine and dehydroepiandrosterone. Cancer Lett 1999;140:75-9.
19. Nishiyama M, Wands JR. Cloning and increased expression of an insulin receptor substrate-1-like gene in human hepatocellular carcinoma. Biochem Biophys Res Commun 1992;183:280-5.
20. Tanaka S, Wands JR. A carboxy-terminal truncated insulin receptor substrate-1 dominant negative protein reverses the human hepatocellular carcinoma malignant phenotype. J Clin Investig 1996;98:2100-8.
21. Tanaka S, Wands JR. Insulin receptor substrate 1 overexpression in human hepatocellular carcinoma cells prevents transforming growth factor beta1-induced apoptosis. Cancer Res 1996;56:3391-4.
22. Tanaka S, Ito T, Wands JR. Neoplastic transformation induced by insulin receptor substrate-1 overexpression requires an interaction with both Grb2 and Syp signaling molecules. J Biol Chem 1996;271:14610-6.
23. Tanaka S, Mohr L, Schmidt EV, Sugimachi K, Wands JR. Biological effects of human insulin receptor substrate-1 overexpression in hepatocytes. Hepatology 1997;26:598-604.
24. Toyoda M, Hashimoto N, Tokita K, et al. Increased activity and expression of MAP kinase in HCC model rats induced by 3′-methyl-4-dimethylamino- azobenzene. J Hepatol 1999;31:725-33.
25. Dombrowski F, Lehringer-Polzin M, Pfeifer U. Hyperproliferative liver acini after intraportal islet transplantation in streptozotocin-induced diabetic rats. Lab Investig 1994;71:688-99.
26. Dombrowski F, Filsinger E, Bannasch P, Pfeifer U. Altered liver acini induced in diabetic rats by portal vein islet isografts resemble preneoplastic hepatic foci in their enzymic pattern. Am J Pathol 1996;148:1249-56.
27. Dombrowski F, Bannasch P, Pfeifer U. Hepatocellular neoplasms induced by low-number pancreatic islet transplants in streptozotocin diabetic rats. Am J Pathol 1997;150:1071-87.
28. Bannasch P, Enzmann H, Klimek F, Weber E, Zerban H. Significance of sequential cellular changes inside and outside foci of altered hepatocytes during hepatocarcinogenesis. Toxicol Pathol 1989;17:617-28.
29. Scharf JG, Ramadori G, Dombrowski F. Analysis of the IGF axis in preneoplastic hepatic foci and hepatocellular neoplasms developing after low-number pancreatic islet transplantation into the livers of streptozotocin diabetic rats. Lab Investig 2000;80:1399-411.
30. Scharf IG, Dombrowski F, Ramadori G. The IGF axis and hepatocarcinogenesis. Mol Pathol 2001;54:138-44.
31. Evert M, Ott T, Temme A, Willecke K, Dombrowski F. Morphology and morphometric investigation of hepatocellular preneoplastic lesions and neoplasms in connexin32-deflcient mice. Carcinogenesis (Lond) 2002;23:697-703.
32. Unger J, McNeill TH, Moxley RT III, White M, Moss A, Livingston JN. Distribution of insulin receptor-like immunoreactivity in the rat forebrain. Neuroscience 1989;31:143-57.
33. Roth J, Bendayan M, Carlemalm E, Villiger W, Garavito M. Enhancement of structural preservation and immunocytochemical staining in low temperature embedded pancreatic tissue. J Histochem Cytochem 1981;29:663-71.
34. De Waele M, De Mey J, Moeremans M, De Brabander M, Van Camp B. Immunogold staining method for the light microscopic detection of leukocyte cell surface antigens with monoclonal antibodies: its application to the enumeration of lymphocyte subpopulations. J Histochem Cytochem 1983;31:376-81.
35. Gee B, Warhol MJ, Roth J. Use of anti-horseradish peroxidase antibody-gold complex in the ABC technique. J Histochem Cytochem 1991;39:863-9.
36. Varndell IM, Tapia FJ, Probert L, et al. Immunogold staining procedure for the localisation of regulatory peptides. Peptides 1982;3:259-72.
37. Zhou H, Sziegoleit A, Fischer HP. Immunocytochemical localization of elastase 1 in human pancreas. Histochem Cell Biol 1995;103:103-9.
38. Herbst H, Milani S, Schuppan D, Stein H. Temporal and spatial patterns of protooncogene expression at early stages of toxic liver injury in the rat. Lab Investig 1991;65:324-33.
39. Evert M, Schneider-Stock R, Dombrowski F. Apolipoprotein A-IV mRNA overexpression in early preneoplastic hepatic foci induced by low-number pancreatic islet transplants in streptozotocin-diabetic rats. Pathol Res Pract 2003;199:373-9.
40. Krones A, Kietzmann T, Jungermann K. Perivenous localization of insulin receptor protein in rat liver, and regulation of its expression by glucose and oxygen in hepatocyte cultures. Biochem J 2000;348:433-8.
41. Koh G, Robinson KA, Buse MG. Delayed processing of the insulin proreceptor by hepatocytes from diabetic rats. Biochem Biophys Res Commun 1994;204:725-31.
42. Tozzo E, Desbuquois B. Effects of STZ-induced diabetes and fasting on insulin receptor mRNA expression and insulin receptor gene transcription in rat liver. Diabetes 1992;41:1609-16.
43. Sechi LA, Griffin CA, Grady EF, Grunfeld C, Kalinyak JE, Schambelan M. Tissue-specific regulation of insulin receptor mRNA levels in rats with STZ-induced diabetes mellitus. Diabetes 1992;41:1113-8.
44. Sugaya H, Ozaki S. The effect of insulin and glucagon on the insulin receptor of cultured hepatoma cells. Gastroenterol Jpn 1986;21:365-73.
45. Dumonteil E, Magnan C, Ritz-Laser B, et al. Insulin, but not glucose lowering corrects the hyperglucagonemia and increased proglucagon messenger ribonucleic acid levels observed in insulinopenic diabetes. Endocrinology 1998;139:4540-6.
46. Charles MA, Imagawa W, Forsham PH, Grodsky GM. Islet transplantation into rat liver: in vitro secretion of insulin from the isolated perfused liver and in vivo glucagon suppression. Endocrinology 1976;98:738-42.
47. Patel DG. Effect of prolonged insulin treatment on blunted plasma catecholamine and glucagon increase during insulin hypoglycemia in streptozotocin diabetic rats. Metabolism 1983;32:377-82.
48. D'Ambrosio C, Keller SR, Morrione A, Lienhard GE, Baserga R, Surmacz E. Transforming potential of the insulin receptor substrate 1. Cell Growth Differ 1995;6:557-62.
49. Wiedmann M, Tamaki S, Silberman R, de la Monte SM, Cousens L, Wands JR. Constitutive over-expression of the insulin receptor substrate-1 causes functional up-regulation of Fas receptor. J Hepatol 2003;38:803-10.